Brief: Hansa Biopharma Says Restructuring To Optimize Resource Allocation, Save 40-50 SEK Mln Annually
26/05/2025 17:42
May 26 (Reuters) - Hansa Biopharma AB HNSA.ST: HANSA BIOPHARMA PLANS RESTRUCTURING TO OPTIMIZE RESOURCE ALLOCATION AND IMPROVE OPERATIONAL EFFICIENCY HANSA BIOPHARMA AB - RESTRUCTURING TO REDUCE WORKFORCE BY 20%, SAVE 40-50 MSEK ANNUALLY Source text: ID:nWkrbKg4Tk Further company coverage: HNSA.ST ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Hansa Biopharma AB
See all newsBrief: Hansa Biopharma Q3 Rev Up At SEK 143 Mln
Sweden's Hansa Biopharma Q3 revenue surges on SERB license deal
Brief: Hansa Biopharma Q3 Net Income SEK -178.5 Million
Brief: Hansa Biopharma Announces Positive Idefirix Paes Results Presented In The High-Impact Clinical Trials Session At Asn Kidney Week
Brief: Hansa Biopharma Submits IND Application To FDA For HNSA-5487 In GBS